A strengthening financial division and a growing sales backlog portend a brightening future for GE, but the consolidated numbers coming from GE for 3Q were well below par.
GE’s 3Q numbers fall
A strengthening financial division and a growing sales backlog portend a brightening future for GE, but the consolidated numbers coming from GE for 3Q were well below par. In a financial release Oct. 16, the company reported that revenues fell to $37.8 billion, off 20% compared to the previous year’s third quarter, and earnings fell to $2.5 billion, down 51% from the previous year period. A breakdown of data regarding financial performance related to healthcare products and services were not immediately available.
Large Study Affirms Safety of Ultrasound Enhancing Agents for Echocardiography
May 16th 2025Those receiving ultrasound enhancing agents (UEAs) for transthoracic or stress echocardiography had lower odds of all-cause death in comparison to patients who did not have UEAs, according to a nationwide study involving 11.4 million patients.
BrightHeart Garners Third FDA Clearance for AI-Powered Assessments of Fetal Heart Ultrasound
May 14th 2025The latest FDA 510(k) clearance is for B-Right Views, an AI-enabled device, which provides automated detection of required views necessary for second- and third-trimester fetal heart ultrasound exams.